Sotera Health outlines 2025-27 growth plan; warns of 2024 EBITDA risk from USD strength

Sotera Health Co

Targets organic revenue CAGR of 5-7% and adjusted EBITDA CAGR of 5-8% for 2025-2027.
Aims to expand adjusted EBITDA margins by at least 50 bps and generate cumulative FCF >$500M.
Sees serviceable addressable market of $18B; highlights strategic positioning and durable customer relationships.
Notes risk that 2024 Adjusted EBITDA could fall modestly below guidance due to recent USD strengthening.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.